Simona Soverini, Caterina De Benedittis, Cristina Papayannidis, Luca Zazzeroni, Claudia Venturi, Ilaria Iacobucci, Domenico Russo, Paola Bresciani, Mario Luppi, Michele Baccarani, Michele Cavo, Giovanni Martinelli, Backtracking BCR-ABL1 Mutants in Philadelphia-Positive Acute Lymphoblastic Leukemia Patients Relapsing on Tyrosine Kinase Inhibitors with Deep Sequencing: Implications for Routine Mutation Testing, «BLOOD», 2014, 124, pp. 2259 - 2259 [Abstract]
Lucia Pantani;Elena Zamagni;Beatrice Anna Zannetti;Annalisa Pezzi;Paola Tacchetti;Annamaria Brioli;Katia Mancuso;Giulia Perrone;Serena Rocchi;Patrizia Tosi;Michele Cavo, Bortezomib and dexamethasone as salvage therapy in patients with relapsed/refractory multiple myeloma: analysis of long-term clinical outcomes, «ANNALS OF HEMATOLOGY», 2014, 93, pp. 123 - 128 [Scientific article]
Tacchetti, P.; Terragna, C.; Galli, M.; Zamagni, E.; Petrucci, M. T.; Pezzi, A.; Montefusco, V.; Martello, M.; Tosi, P.; Baldini, L.; Peccatori, J.; Ruggieri, M.; Pantani, L.; Lazzaro, A.; Elice, F.; Rocchi, S.; Gozzetti, A.; Cavaletti, G.; Palumbo, A.; Cavo, M., Bortezomib- and thalidomide-induced peripheral neuropathy in multiple myeloma: clinical and molecular analyses of a phase 3 study., «AMERICAN JOURNAL OF HEMATOLOGY», 2014, 89, pp. 1085 - 1091 [Scientific article]
Morabito F.; Bringhen S.; Larocca A.; Wijermans P.; Victoria Mateos M.; Gimsing P.; Mazzone C.; Gottardi D.; Omede P.; Zweegman S.; Jose Lahuerta J.; Zambello R.; Musto P.; Magarotto V.; Schaafsma M.; Oriol A.; Juliusson G.; Cerrato C.; Catalano L.; Gentile M.; Isabel Turel A.; Marina Liberati A.; Cavalli M.; Rossi D.; Passera R.; Rosso S.; Beksac M.; Cavo M.; Waage A.; San Miguel J.; Boccadoro M.; Sonneveld P.; Palumbo A.; Offidani M., Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case-matched study, «AMERICAN JOURNAL OF HEMATOLOGY», 2014, 89, pp. 355 - 362 [Scientific article]
Palumbo A.; Bringhen S.; Larocca A.; Rossi D.; Di Raimondo F.; Magarotto V.; Patriarca F.; Levi A.; Benevolo G.; Vincelli I.D.; Grasso M.; Franceschini L.; Gottardi D.; Zambello R.; Montefusco V.; Falcone A.P.; Omede P.; Marasca R.; Morabito F.; Mina R.; Guglielmelli T.; Nozzoli C.; Passera R.; Gaidano G.; Offidani M.; Ria R.; Petrucci M.T.; Musto P.; Boccadoro M.; Cavo M., Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: Updated follow-up and improved survival, «JOURNAL OF CLINICAL ONCOLOGY», 2014, 32, pp. 634 - 640 [Scientific article]
Marilena Mancino;Stefano Grosso;Carolina Terragna;Enrica Borsi;Michele Cavo;Stefano Biffo, Cap dependent translation contributes to resistance of myeloma cells to bortezomib, «TRANSLATION», 2014, 1, pp. e27245-1 - e27245-8 [Scientific article]
Moreau, P; Cavo, M; Sonneveld, P; Rosinol, L; Attal, M; Pezzi, A; Goldschmidt, H; Lahuerta, Jj; Marit, G; Palumbo, A; van der Holt, B; Bladé, J; Petrucci, Mt; Neben, K; san Miguel, J; Patriarca, F; Lokhorst, H; Zamagni, E; Hulin, C; Gutierrez, N; Facon, T; Caillot, D; Benboubker, L; Harousseau, Jl; Leleu, X; Avet-Loiseau, H; Mary, Jy, Combination of international scoring system 3, high lactate dehydrogenase, and t(4;14) and/or del(17p) identifies patients with multiple myeloma (MM) treated with front-line autologous stem-cell transplantation at high risk of early MM progression-related death., «JOURNAL OF CLINICAL ONCOLOGY», 2014, 32, pp. 2173 - 2180 [Scientific article]
De Benedittis C, Soverini S, Machova Polakova K, Brouckova A, Rosti G, Castagnetti F, Gugliotta G, Papayannidis C, Klamova H, Iacobucci I, Russo D, Martínez Lopez J, Barrio S, Baccarani M, Cavo M, Martinelli G, Deep sequencing of the bcr-abl kinase domain reveals a high frequency of bcr-abl35-ins insertion/truncation mutation in chronic myeloid leukemia and Philadelphia positive acute lymphoblastic leukemia patients, in: ABSTRACTS, 2014, pp. 10 - 10 (atti di: ELN FRONTIERS MEETING - WHERE SCIENCE MEETS CLINICAL PRACTICE, BERLIN, GERMANY, 16 – 19 OCTOBER 2014) [Abstract]
Antonio Curti, Loredana Ruggeri, Sarah Parisi, Andrea Bontadini, Elisa Dan, Simonetta Rizzi, Maria Rosa Motta, Sara Trabanelli, Darina Ocadlikova, Mariangela Lecciso, Valeria Giudice, Elena Urbani, Cristina Papayannidis, Giovanni Martinelli, Francesca Bonifazi, Giuseppe Bandini, Fiorenza Fruet, Russel E. Lewis, Michele Cavo, Andrea Velardi, Roberto M. Lemoli, Donor Natural Killer (NK) Alloreactivity Predicts Long-Term Relapse-Free Survival in Acute Myeloid Leukemia Patients Undergoing Immunotherapy with NK Cells, «BLOOD», 2014, 124, pp. 624 - 624 [Abstract]
Soverini, S.; De Benedittis, C.; Papayannidis, C.; Paolini, S.; Venturi, C.; Iacobucci, I.; Luppi, M.; Bresciani, P.; Salvucci, M.; Russo, D.; Sica, S.; Orlandi, E.; Intermesoli, T.; Gozzini, A.; Bonifacio, M.; Rigolin, G.M.; Pane, F.; Baccarani, M.; Cavo, M.; Martinelli, G., Drug resistance and BCR-ABL kinase domain mutations in Philadelphia chromosome-positive acute lymphoblastic leukemia from the imatinib to the second-generation tyrosine kinase inhibitor era: The main changes are in the type of mutations, but not in the frequency of mutation involvement, «CANCER», 2014, 120, pp. 1002 - 1009 [Scientific article]
Engelhardt M.; Terpos E.; Kleber M.; Gay F.; Wasch R.; Morgan G.; Cavo M.; van de Donk N.; Beilhack A.; Bruno B.; Johnsen H.E.; Hajek R.; Driessen C.; Ludwig H.; Beksac M.; Boccadoro M.; Straka C.; Brighen S.; Gramatzki M.; Larocca A.; Lokhorst H.; Magarotto V.; Morabito F.; Dimopoulos M.A.; Einsele H.; Sonneveld P.; Palumbo A., European myeloma network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma, «HAEMATOLOGICA», 2014, 99, pp. 232 - 242 [Scientific article]
Ludwig H.; Sonneveld P.; Davies F.; Blade J.; Boccadoro M.; Cavo M.; Morgan G.; de la Rubia J.; Delforge M.; Dimopoulos M.; Einsele H.; Facon T.; Goldschmidt H.; Moreau P.; Nahi H.; Plesner T.; San-Miguel J.; Hajek R.; Sondergeld P.; Palumbo A., European perspective on multiple myeloma treatment strategies in 2014, «THE ONCOLOGIST», 2014, 19, pp. 829 - 844 [Scientific article]
Dimopoulos M.A.; Leleu X.; Palumbo A.; Moreau P.; Delforge M.; Cavo M.; Ludwig H.; Morgan G.J.; Davies F.E.; Sonneveld P.; Schey S.A.; Zweegman S.; Hansson M.; Weisel K.; Mateos M.V.; Facon T.; Miguel J.F.S., Expert panel consensus statement on the optimal use of pomalidomide in relapsed and refractory multiple myeloma, «LEUKEMIA», 2014, 28, pp. 1573 - 1585 [Scientific article]
Gabriele Gugliotta;Fausto Castagnetti;Michela Apolinari;Sara Pirondi;Michele Cavo;Michele Baccarani;Gianantonio Rosti, First-Line Treatment of Newly Diagnosed Elderly Patients with Chronic Myeloid Leukemia: Current and Emerging Strategies, «DRUGS», 2014, 74, pp. 627 - 643 [Scientific article]
F. Bonifazi;G. Storci;G. Bandini;E. Marasco;E. Dan;E. Zani;F. Albani;S. Bertoni;A. Bontadini;S. De Carolis;M. R. Sapienza;S Rizzi;M. R. Motta;M. Ferioli;P. Garagnani;M. Cavo;V. Mantovani;M. Bonafe, Glutathione transferase-A2 S112T polymorphism predicts survival, transplant-related mortality, busulfan and bilirubin blood levels after allogeneic stem cell transplantation, «HAEMATOLOGICA», 2014, 99, pp. 172 - 179 [Scientific article]Open Access
